Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis

Biogen · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
msmultiple-sclerosis
relapsing-remitting multiple sclerosis, ms, multiple sclerosis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 842634
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.